antibiotic g 418 has been researched along with Colonic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Light, Y; Marais, R; Martin, J; Spooner, RA; Springer, CJ | 1 |
Grogan, L; Hausner, P; Kirsch, IR; Venzon, DJ | 1 |
2 other study(ies) available for antibiotic g 418 and Colonic Neoplasms
Article | Year |
---|---|
Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Colonic Neoplasms; COS Cells; Drug Screening Assays, Antitumor; Female; gamma-Glutamyl Hydrolase; Genetic Therapy; Genetic Vectors; Gentamicins; Glutamates; Humans; Mutagenesis, Site-Directed; Nitrogen Mustard Compounds; Ovarian Neoplasms; Prodrugs; Transfection; Tumor Cells, Cultured | 1996 |
The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterations.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Culture Techniques; Cell Division; Coculture Techniques; Colonic Neoplasms; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Dyes; Genetic Vectors; Gentamicins; Green Fluorescent Proteins; Humans; Luminescent Proteins; Methylnitronitrosoguanidine; Mitoxantrone; Mutation; Neoplasm Proteins; Time Factors; Transfection; Tumor Cells, Cultured | 1999 |